Kato K.
Omi M*, Fusegi A*, Takeshima N*
Modified posterior pelvic exenteration with pelvic side-wall resection requiring both intestinal and urinary reconstruction during surgery for ovarian cancer
Gynecologic Oncology 155: 172-173, 2019
Komiyama S*.
Kato K, Inokuchi Y*, Takano H*, Matsumoto T*, Hongo A*, Asai-Sato M*, Arakawa A*, Kamiura S*, Tabata T*, Takeshima N*, Sugiyama T*
Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial)
Int J Clin Oncol 24: 103-114, 2019
Nomura H*.
Sugiyama Y*, Ito T*, Furuta N*, Komatsu K*, Takazawa Y*, Aoki Y*, Tanigawa T*, Matoda M*, Okamoto S*, Kanao H*, Omatsu K*, Kato K, Utsugi K*, Takeshima N*
Clinical management of the status of atypical endometrial cells using the descriptive reporting format for endometrial cytology
Cytopathology 30: 209-214, 2019
Tsuchida N.
Kojima J, Fukuda A*, Oda M*, Kawasaki T*, Ito H, Kuji N, Isaka K,Nishi H, Umezawa A*, Akutsu H*
Transcriptomic features of trophoblast lineage cells derived from human induced pluripotent stem cells treated with BMP 4
Placenta. 2019 Oct 9(89): 20-32, 2019